AVITA Medical, Inc.
RCEL
$4.62
$0.225.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.45% | 20.59% | 38.32% | 41.35% | 28.14% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.45% | 20.59% | 38.32% | 41.35% | 28.14% |
| Cost of Revenue | 40.68% | 36.69% | 56.27% | 36.56% | 16.89% |
| Gross Profit | 6.63% | 17.89% | 35.42% | 42.20% | 30.20% |
| SG&A Expenses | -11.90% | -6.14% | 10.15% | 25.73% | 39.28% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.54% | -3.75% | 12.04% | 22.09% | 30.23% |
| Operating Income | 24.84% | 28.56% | 14.10% | -2.54% | -32.70% |
| Income Before Tax | 21.38% | 15.30% | -3.67% | -27.40% | -74.97% |
| Income Tax Expenses | -81.48% | -2.13% | -96.51% | -51.52% | -18.18% |
| Earnings from Continuing Operations | 21.44% | 15.29% | -3.50% | -27.28% | -74.80% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 21.44% | 15.29% | -3.50% | -27.28% | -74.80% |
| EBIT | 24.84% | 28.56% | 14.10% | -2.54% | -32.70% |
| EBITDA | 27.45% | 30.99% | 16.23% | -1.07% | -32.01% |
| EPS Basic | 26.80% | 18.62% | -1.31% | -24.60% | -71.18% |
| Normalized Basic EPS | 28.49% | 27.70% | 12.51% | -5.64% | -40.80% |
| EPS Diluted | 26.80% | 18.62% | -1.31% | -24.60% | -70.66% |
| Normalized Diluted EPS | 28.49% | 27.70% | 12.51% | -5.64% | -40.80% |
| Average Basic Shares Outstanding | 7.60% | 4.18% | 2.42% | 2.35% | 2.18% |
| Average Diluted Shares Outstanding | 7.60% | 4.18% | 2.42% | 2.35% | 2.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |